Kyntra Bio CFO Sells 60 Shares Amid Insider Sales Wave as Stock Tumbles 38% YTD
Insider sales at Kyntra Bio reveal tax‑related moves, not a sharp decline. Watch Phase 1b/2 FG‑3246 data before betting on the stock’s future.
2 minutes to read
Kyntra Bio Inc